No Prescription |
 |
 | ||
|
Rizact Maxalt |
|
| ||
No Prescription » Prescription Drugs 14 » Rizact Maxalt Rizatriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Rizatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain stopping pain signals from being sent to the brain and stopping the release of certain natural substances that cause pain nausea and other symptoms of migraine. Rizatriptan does not prevent migraine attacks.Rizatriptan comes as a tablet and an orally disintegrating tablet to take by mouth. It should be taken at the first sign of a migraine headache. If you are at risk for heart disease and you have never taken rizatriptan before you may need to take the first dose in your doctor's office. Usually only one dose is needed. If pain is not relieved with the first dose your doctor may prescribe a second dose to be taken 2 hours after the first dose. Do not take more than 30 mg of rizatriptan in any 24-hour period. If you are also taking propranolol (Inderal) you should not take more than 15 mg of rizatriptan in any 24-hour period. Follow the directions on the package or prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take rizatriptan exactly as directed. Do not take more or less of it or take it more often than directed by the package label or prescribed by your doctor.The orally disintegrating tablet should not be removed from the package until just before it is taken. The packet should be opened with dry hands and the orally disintegrating tablet should be placed on the tongue where it will dissolve and be swallowed with saliva. Buy Rizact Maxalt and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Rizact Maxalt: Product Type: Prescription Drugs 14 Rizact ( Maxalt Generic Rizatriptan ) Rizact (Maxalt Generic Rizatriptan) Maxalt Generic Rizatriptan 10 mg Tabs Maxalt Generic Rizatriptan Rizact
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
